Monday, 16 March 2015

The Top 10 Tricks Used by Corporate Junk Science

"Only 3 of the 78 publications (4%) that resulted from trials in which the FDA found significant violations mentioned the objectionable conditions or practices found during the inspection. No corrections, retractions, expressions of concern, or other comments acknowledging the key issues identified by the inspection were subsequently published."

No comments:

Post a Comment